R. Hasselback

692 total citations
20 papers, 554 citations indexed

About

R. Hasselback is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, R. Hasselback has authored 20 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Oncology. Recurrent topics in R. Hasselback's work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Neutropenia and Cancer Infections (3 papers). R. Hasselback is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Neutropenia and Cancer Infections (3 papers). R. Hasselback collaborates with scholars based in Canada and Norway. R. Hasselback's co-authors include Daniel E. Bergsagel, D. H. Cowan, Peter Fredrik Hjort, Gary L. Robertson, J. E. Curtis, Ronald Feld, Peter G. Tuffnell, Bruce Patterson, Anne Matlow and Eliane Haron and has published in prestigious journals such as Science, The Lancet and Journal of Clinical Oncology.

In The Last Decade

R. Hasselback

20 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Hasselback Canada 13 205 185 113 99 99 20 554
Leroy Fass United States 13 167 0.8× 274 1.5× 64 0.6× 61 0.6× 143 1.4× 26 747
L. J. Dooren Netherlands 10 259 1.3× 81 0.4× 37 0.3× 107 1.1× 104 1.1× 24 566
TA Fleisher United States 8 202 1.0× 353 1.9× 48 0.4× 93 0.9× 115 1.2× 13 849
P Dujardin France 11 135 0.7× 78 0.4× 42 0.4× 61 0.6× 109 1.1× 101 443
EP Smith United States 8 387 1.9× 256 1.4× 60 0.5× 44 0.4× 134 1.4× 11 697
M. J. Leyland United Kingdom 14 295 1.4× 157 0.8× 72 0.6× 101 1.0× 48 0.5× 33 695
W Sizoo Netherlands 17 435 2.1× 249 1.3× 54 0.5× 119 1.2× 78 0.8× 38 787
R Cuthbert United Kingdom 14 196 1.0× 64 0.3× 48 0.4× 72 0.7× 81 0.8× 40 607
Mark Arneson United States 12 248 1.2× 189 1.0× 213 1.9× 266 2.7× 164 1.7× 14 796
Karl G. Blume United States 8 369 1.8× 173 0.9× 61 0.5× 36 0.4× 99 1.0× 9 545

Countries citing papers authored by R. Hasselback

Since Specialization
Citations

This map shows the geographic impact of R. Hasselback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hasselback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hasselback more than expected).

Fields of papers citing papers by R. Hasselback

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Hasselback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hasselback. The network helps show where R. Hasselback may publish in the future.

Co-authorship network of co-authors of R. Hasselback

This figure shows the co-authorship network connecting the top 25 collaborators of R. Hasselback. A scholar is included among the top collaborators of R. Hasselback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Hasselback. R. Hasselback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haron, Eliane, Ronald Feld, Peter G. Tuffnell, et al.. (1987). Hepatic Candidiasis: An increasing problem in immunocompromised patients. The American Journal of Medicine. 83(1). 17–26. 103 indexed citations
2.
Curtis, J. E., Hans A. Messner, R. Hasselback, T Elhakim, & E. A. McCulloch. (1984). Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia.. Journal of Clinical Oncology. 2(4). 253–259. 37 indexed citations
3.
Tc, Brown, T. Chua, D. Dalley, et al.. (1982). Results of treating Hodgkin's disease without a policy of laparotomy staging.. PubMed. 66(4). 717–31. 58 indexed citations
4.
Pruzanski, W., et al.. (1978). Multiple myeloma (light chain disease) with rheumatoid-like amyloid arthropathy and μ-heavy chain fragment in the serum. The American Journal of Medicine. 65(2). 334–341. 21 indexed citations
5.
Curtis, J. E., R. Hasselback, & Daniel E. Bergsagel. (1977). Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia.. PubMed. 117(4). 341–5. 12 indexed citations
6.
Manaster, J., et al.. (1976). Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).. PubMed. 59(3). 537–45. 10 indexed citations
7.
Curtis, J. E., D. H. Cowan, Daniel E. Bergsagel, R. Hasselback, & E. A. McCulloch. (1975). Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.. PubMed. 113(4). 289–94. 39 indexed citations
8.
Bergsagel, Daniel E., D. H. Cowan, & R. Hasselback. (1972). Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.. PubMed. 107(9). 851–5. 65 indexed citations
9.
Abu-Zahra, Hakam, Albert Clarysse, D. H. Cowan, R. Hasselback, & Daniel E. Bergsagel. (1972). Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine.. PubMed. 107(11). 1073–8. 9 indexed citations
10.
Abu-Zahra, Hakam, Dante Amato, R. Hasselback, et al.. (1972). Bone marrow transplantation in patients with acute leukaemia.. PubMed. 5(2). 189–204. 4 indexed citations
11.
Abu-Zahra, Hakam, et al.. (1971). OCCURRENCE OF AUSTRALIA ANTIGEN IN PATIENTS WITH LEUKÆMIA IN CANADA. The Lancet. 298(7720). 375–376. 6 indexed citations
12.
Bergsagel, Daniel E., Gary L. Robertson, & R. Hasselback. (1968). Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.. PubMed. 98(11). 532–8. 51 indexed citations
13.
Hasselback, R., et al.. (1967). The influence of morphology on prognosis in acute leukemia.. PubMed. 96(25). 1610–4. 18 indexed citations
14.
Hasselback, R., et al.. (1963). Congenital hypofibrinogenemia in five members of a family.. PubMed. 88. 19–22. 29 indexed citations
15.
Almeida, June D., R. Hasselback, & A. W. Ham. (1963). Virus-Like Particles in Blood of Two Acute Leukemia Patients. Science. 142(3598). 1487–1489. 25 indexed citations
16.
Hasselback, R., et al.. (1961). A critical review of the evidence for a continous hemostasis in vivo.. PubMed. 6. 580–612. 7 indexed citations
17.
Hasselback, R., et al.. (1961). Blood banking. I. Abnormal antibodies and their detection.. PubMed. 84. 781–5. 2 indexed citations
18.
McGeer, P. L., Edith G. McGeer, & R. Hasselback. (1961). Preliminary Survey of 4-Amino-5-Imidazolecarboxamide Excretion in Leukemia and Other Illnesses.. PubMed. 85(8). 437–9. 5 indexed citations
19.
Hjort, Peter Fredrik & R. Hasselback. (1961). A Critical Review of the Evidence for a Continuous Hemostasis in vivo. Thrombosis and Haemostasis. 6(3). 580–612. 28 indexed citations
20.
Hasselback, R. & Peter Fredrik Hjort. (1960). Effect of heparin on in vivo turnover of clotting factors. Journal of Applied Physiology. 15(5). 945–948. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leroy Fass Breakdown of academic impact, for papers by L. J. Dooren Breakdown of academic impact, for papers by TA Fleisher Breakdown of academic impact, for papers by P Dujardin Breakdown of academic impact, for papers by EP Smith Breakdown of academic impact, for papers by M. J. Leyland Breakdown of academic impact, for papers by W Sizoo Breakdown of academic impact, for papers by R Cuthbert Breakdown of academic impact, for papers by Mark Arneson Breakdown of academic impact, for papers by Karl G. Blume
Rankless by CCL
2026